Thndr Claps » U.S. Claps » Health & Pharma💉 » GSK set to acquire Sierra Oncology🦠
The ClapBritish healthcare giant GlaxoSmithKline (GSK) is set to acquire Sierra Oncology (NASDAQ: SRRA) for $1.9 billion.
More detailsSierra is a biopharmaceutical company that focuses on the treatment of rare forms of cancer. The offer came in at $55/share, a 39% premium to SRRA’s closing price yesterday.
Why this mattersThe acquisition is set to complement some of GSK’s treatments, including Myeloma, a type of blood cancer.
© Thndr. All rights reserved
Disclaimer: Thndr does not provide investment advice, individual investors are responsible for their own decisions or can seek independent advice. The value of investments can go up and down. Thndr is a trading name of Thndr Securities Brokerage which is authorised and regulated by the Financial Regulatory Authority (FRA). Registered in Egypt (no. 804)..© Thndr. All rights reserved
Hello👋 We want you to be able to express your opinions on anything and everything finance and economics related to the Egyptian and US markets.
This is why we introduced Thndr Thinkers💭
Let’s go through some housekeeping notes before you jump into publishing your article to all Thndr Claps readers!
Type of Content📝 We want to see market-relevant content that shows good analysis, please! Base your articles on facts
Don’t be shy, explain🗣 Flex your knowledge to us, and we’ll share it with all the readers!
Be Original🙏 Please don’t copy. No one likes a copycat. All submissions are welcome as long as they’re yours
Make your title attractive🤩 A title is like the cover of your book. Attractive enough to make you look at the book but also clear enough to tell you what the book is about.
Clean🧹 We’re all humans and we all make mistakes. But please try and clean up the article so it’s clear for all the readers
No promotional content🚫 We don’t publish promotional content.
Any questions about becoming a Thndr Thinker? Email email@example.com and we’d be happy to help!
Normally, your article will be published within 24 hours of submission (if you followed the guidelines)